A61K 38/1751
Bactericidal/permeability-increasing protein [bpi]
Official title: {Bactericidal/permeability-increasing protein [BPI]}
A61K38/1751 (Bactericidal/permeability-increasing protein [bpi]) appears on 89 US grants and 48 published applications in this corpus.
Search patents in A61K- Granted patents
- 89
- Published applications
- 48
- Assignees
- 32
- Inventors
- 75
- Latest grant
- 20 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 8 | 0 |
| 1998 | 8 | 0 |
| 1999 | 12 | 0 |
| 2000 | 11 | 0 |
| 2001 | 7 | 2 |
| 2002 | 5 | 10 |
| 2003 | 9 | 5 |
| 2004 | 1 | 4 |
| 2005 | 2 | 4 |
| 2006 | 3 | 2 |
| 2007 | 1 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 1 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 2 |
| 2016 | 1 | 0 |
| 2017 | 2 | 4 |
| 2018 | 1 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 2 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 1 | 2 |
| 2025 | 2 | 0 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptide for use in the prevention and/or treatment of a disease caused by a virus affecting the respiratory tract20 Jan 2026US 12,527,837 B2Fundacion Para El Fomento De La Investigacion Sanitaria Y Biomedica De La Comunitat Valenciana (Fisabio)
- Variant of a BPIFB4 protein2 Dec 2025US 12,486,308 B2Lgv1 S.R.L.
- Methods for treating huntington's disease using a polynucleotide encoding a VTFT isoform of a BPIFB4 protein27 May 2025US 12,311,009 B2Lgv1 S.R.L.
- Variant of a BPIFB4 protein6 Feb 2024US 11,891,421 B2Lgvi S.R.L.
- Viral vector suitable for gene therapy encoding a variant of a BPIFB4 protein28 Dec 2021US 11,208,447 B2Roxiant Aps
- Interactive security and locking system for dwellings doors12 Sep 2024US 2024/0301718 A1
- Variant of a bpifb4 protein18 Jul 2024US 2024/0239850 A1Lgv1 S.R.L.
- Peptide for use in the prevention and/or treatment of a disease caused by a virus affecting the respiratory tract8 Jun 2023US 2023/0173022 A1FundacióN Para El Fomento De La InvestitacióN Sanitaria Y BioméDica De La Comunitat Valenciana
- Variant of a bpifb4 protein2 Jun 2022US 2022/0169686 A1Roxiant Aps
- Vtft isoform of a bpifb4 protein for use in neuronal diseases and injuries6 May 2021US 2021/0128681 A1Lgv1 S.R.L.
Most cited
By later US patents
- DNA encoding bactericidal/permeability-increasing proteins97US 5,198,541 ANew York University · 1993
- Therapeutic uses of bactericidal/permeability increasing protein products81US 5,348,942 AXoma Corporation · 1994
- Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (BPI) protein product and antibiotic44US 5,523,288 AXoma Corporation · 1996
- Pharmaceutical composition comprising BPI proteins39US 5,488,034 AXoma Corporation · 1996
- Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof39US 5,652,332 AXoma Corporation · 1997